nodes	percent_of_prediction	percent_of_DWPC	metapath
Furosemide—PGD—Dacarbazine—skin cancer	0.461	0.618	CbGbCtD
Furosemide—SLC22A5—Dactinomycin—skin cancer	0.0843	0.113	CbGbCtD
Furosemide—ALB—Vismodegib—skin cancer	0.0778	0.104	CbGbCtD
Furosemide—ALB—Vemurafenib—skin cancer	0.0615	0.0825	CbGbCtD
Furosemide—ABCC2—Docetaxel—skin cancer	0.0339	0.0454	CbGbCtD
Furosemide—ALB—Fluorouracil—skin cancer	0.0276	0.0371	CbGbCtD
Furosemide—CA6—ear—skin cancer	0.00779	0.105	CbGeAlD
Furosemide—Bumetanide—SLC12A2—skin cancer	0.00725	0.898	CrCbGaD
Furosemide—SLC12A1—appendage—skin cancer	0.00534	0.0722	CbGeAlD
Furosemide—CA6—hair follicle—skin cancer	0.00411	0.0555	CbGeAlD
Furosemide—CA1—nerve—skin cancer	0.00261	0.0352	CbGeAlD
Furosemide—CA5A—female reproductive system—skin cancer	0.00216	0.0292	CbGeAlD
Furosemide—CA4—nerve—skin cancer	0.00204	0.0275	CbGeAlD
Furosemide—SLCO2A1—nipple—skin cancer	0.00198	0.0268	CbGeAlD
Furosemide—SLCO2A1—neck—skin cancer	0.00196	0.0265	CbGeAlD
Furosemide—PGD—nipple—skin cancer	0.00177	0.0239	CbGeAlD
Furosemide—PGD—neck—skin cancer	0.00175	0.0237	CbGeAlD
Furosemide—SLC12A1—epithelium—skin cancer	0.00145	0.0196	CbGeAlD
Furosemide—CA2—hair follicle—skin cancer	0.00141	0.0191	CbGeAlD
Furosemide—SLCO2A1—epithelium—skin cancer	0.00134	0.0181	CbGeAlD
Furosemide—CA12—connective tissue—skin cancer	0.00132	0.0179	CbGeAlD
Furosemide—SLCO2A1—skin of body—skin cancer	0.00127	0.0172	CbGeAlD
Furosemide—CA9—female reproductive system—skin cancer	0.00126	0.0171	CbGeAlD
Furosemide—PGD—connective tissue—skin cancer	0.00125	0.017	CbGeAlD
Furosemide—CA6—head—skin cancer	0.00116	0.0157	CbGeAlD
Furosemide—SLCO2A1—mammalian vulva—skin cancer	0.00116	0.0157	CbGeAlD
Furosemide—CA4—nipple—skin cancer	0.00116	0.0156	CbGeAlD
Furosemide—CA4—neck—skin cancer	0.00114	0.0155	CbGeAlD
Furosemide—PGD—skin of body—skin cancer	0.00113	0.0153	CbGeAlD
Furosemide—SLC22A11—female reproductive system—skin cancer	0.00111	0.015	CbGeAlD
Furosemide—PGD—mammalian vulva—skin cancer	0.00103	0.014	CbGeAlD
Furosemide—SLCO2A1—female reproductive system—skin cancer	0.000992	0.0134	CbGeAlD
Furosemide—CA5B—mammalian vulva—skin cancer	0.000978	0.0132	CbGeAlD
Furosemide—CA2—nipple—skin cancer	0.000959	0.013	CbGeAlD
Furosemide—CA2—neck—skin cancer	0.000949	0.0128	CbGeAlD
Furosemide—SLC22A5—nipple—skin cancer	0.000943	0.0128	CbGeAlD
Furosemide—CA12—female reproductive system—skin cancer	0.000934	0.0126	CbGeAlD
Furosemide—PGD—lymphoid tissue—skin cancer	0.000917	0.0124	CbGeAlD
Furosemide—SLC12A1—head—skin cancer	0.000898	0.0121	CbGeAlD
Furosemide—PGD—female reproductive system—skin cancer	0.000884	0.012	CbGeAlD
Furosemide—CA5B—female reproductive system—skin cancer	0.000838	0.0113	CbGeAlD
Furosemide—SLCO2A1—head—skin cancer	0.000829	0.0112	CbGeAlD
Furosemide—Bumetanide—PTGS2—skin cancer	0.000829	0.103	CrCbGaD
Furosemide—CA12—head—skin cancer	0.00078	0.0105	CbGeAlD
Furosemide—CA1—lymphoid tissue—skin cancer	0.000767	0.0104	CbGeAlD
Furosemide—CA1—female reproductive system—skin cancer	0.00074	0.01	CbGeAlD
Furosemide—PGD—head—skin cancer	0.000739	0.00999	CbGeAlD
Furosemide—CA5B—head—skin cancer	0.0007	0.00946	CbGeAlD
Furosemide—CA2—connective tissue—skin cancer	0.00068	0.00919	CbGeAlD
Furosemide—CA2—epithelium—skin cancer	0.000645	0.00873	CbGeAlD
Furosemide—CA1—head—skin cancer	0.000618	0.00836	CbGeAlD
Furosemide—CA2—skin of body—skin cancer	0.000614	0.0083	CbGeAlD
Furosemide—ABCC2—female reproductive system—skin cancer	0.000609	0.00823	CbGeAlD
Furosemide—SLC22A5—skin of body—skin cancer	0.000604	0.00817	CbGeAlD
Furosemide—SLCO2A1—lymph node—skin cancer	0.00058	0.00785	CbGeAlD
Furosemide—CA4—female reproductive system—skin cancer	0.000578	0.00782	CbGeAlD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—skin cancer	0.000575	0.00334	CcSEcCtD
Furosemide—Toxic epidermal necrolysis—Dactinomycin—skin cancer	0.000575	0.00334	CcSEcCtD
Furosemide—Vomiting—Vismodegib—skin cancer	0.000571	0.00332	CcSEcCtD
Furosemide—Drug interaction—Docetaxel—skin cancer	0.00057	0.00331	CcSEcCtD
Furosemide—Rash—Vismodegib—skin cancer	0.000566	0.00329	CcSEcCtD
Furosemide—Dermatitis—Vismodegib—skin cancer	0.000566	0.00329	CcSEcCtD
Furosemide—CA2—mammalian vulva—skin cancer	0.00056	0.00757	CbGeAlD
Furosemide—Dermatitis bullous—Fluorouracil—skin cancer	0.000556	0.00323	CcSEcCtD
Furosemide—Hearing impaired—Docetaxel—skin cancer	0.000555	0.00322	CcSEcCtD
Furosemide—Anaphylactic shock—Vemurafenib—skin cancer	0.000555	0.00322	CcSEcCtD
Furosemide—Nervous system disorder—Vemurafenib—skin cancer	0.000544	0.00316	CcSEcCtD
Furosemide—Lethargy—Fluorouracil—skin cancer	0.000543	0.00315	CcSEcCtD
Furosemide—Skin disorder—Vemurafenib—skin cancer	0.000539	0.00313	CcSEcCtD
Furosemide—Dehydration—Temozolomide—skin cancer	0.000537	0.00312	CcSEcCtD
Furosemide—Nausea—Vismodegib—skin cancer	0.000534	0.0031	CcSEcCtD
Furosemide—Agitation—Imiquimod—skin cancer	0.000533	0.00309	CcSEcCtD
Furosemide—Hypokalaemia—Temozolomide—skin cancer	0.000525	0.00305	CcSEcCtD
Furosemide—SLC22A8—head—skin cancer	0.000521	0.00705	CbGeAlD
Furosemide—Toxic epidermal necrolysis—Temozolomide—skin cancer	0.00052	0.00302	CcSEcCtD
Furosemide—Hypotension—Vemurafenib—skin cancer	0.000519	0.00301	CcSEcCtD
Furosemide—PGD—lymph node—skin cancer	0.000517	0.00699	CbGeAlD
Furosemide—Muscular weakness—Temozolomide—skin cancer	0.000509	0.00296	CcSEcCtD
Furosemide—Irritability—Fluorouracil—skin cancer	0.000507	0.00295	CcSEcCtD
Furosemide—Abdominal distension—Temozolomide—skin cancer	0.000502	0.00292	CcSEcCtD
Furosemide—CA2—lymphoid tissue—skin cancer	0.000497	0.00672	CbGeAlD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Imiquimod—skin cancer	0.00049	0.00285	CcSEcCtD
Furosemide—CA5B—lymph node—skin cancer	0.00049	0.00663	CbGeAlD
Furosemide—Stevens-Johnson syndrome—Dactinomycin—skin cancer	0.000487	0.00283	CcSEcCtD
Furosemide—CA4—head—skin cancer	0.000483	0.00653	CbGeAlD
Furosemide—Dry mouth—Imiquimod—skin cancer	0.000483	0.0028	CcSEcCtD
Furosemide—Decreased appetite—Vemurafenib—skin cancer	0.000482	0.0028	CcSEcCtD
Furosemide—CA2—female reproductive system—skin cancer	0.00048	0.00648	CbGeAlD
Furosemide—Gastrointestinal disorder—Vemurafenib—skin cancer	0.000479	0.00278	CcSEcCtD
Furosemide—Fatigue—Vemurafenib—skin cancer	0.000478	0.00278	CcSEcCtD
Furosemide—Constipation—Vemurafenib—skin cancer	0.000475	0.00276	CcSEcCtD
Furosemide—Lightheadedness—Docetaxel—skin cancer	0.000473	0.00275	CcSEcCtD
Furosemide—SLC22A5—female reproductive system—skin cancer	0.000472	0.00638	CbGeAlD
Furosemide—Muscular weakness—Fluorouracil—skin cancer	0.000469	0.00272	CcSEcCtD
Furosemide—Shock—Imiquimod—skin cancer	0.000466	0.0027	CcSEcCtD
Furosemide—Nervous system disorder—Imiquimod—skin cancer	0.000464	0.00269	CcSEcCtD
Furosemide—Pollakiuria—Temozolomide—skin cancer	0.000461	0.00268	CcSEcCtD
Furosemide—Skin disorder—Imiquimod—skin cancer	0.00046	0.00267	CcSEcCtD
Furosemide—Agranulocytosis—Dactinomycin—skin cancer	0.000459	0.00266	CcSEcCtD
Furosemide—Hyperhidrosis—Imiquimod—skin cancer	0.000458	0.00266	CcSEcCtD
Furosemide—Photosensitivity reaction—Temozolomide—skin cancer	0.000455	0.00264	CcSEcCtD
Furosemide—Eosinophilia—Fluorouracil—skin cancer	0.000455	0.00264	CcSEcCtD
Furosemide—Anorexia—Imiquimod—skin cancer	0.000451	0.00262	CcSEcCtD
Furosemide—Hyperglycaemia—Temozolomide—skin cancer	0.00045	0.00261	CcSEcCtD
Furosemide—Thrombophlebitis—Docetaxel—skin cancer	0.000443	0.00257	CcSEcCtD
Furosemide—Stevens-Johnson syndrome—Temozolomide—skin cancer	0.000441	0.00256	CcSEcCtD
Furosemide—Body temperature increased—Vemurafenib—skin cancer	0.000439	0.00255	CcSEcCtD
Furosemide—Swelling—Docetaxel—skin cancer	0.000435	0.00253	CcSEcCtD
Furosemide—CA1—lymph node—skin cancer	0.000433	0.00585	CbGeAlD
Furosemide—Deafness—Docetaxel—skin cancer	0.000429	0.00249	CcSEcCtD
Furosemide—Paraesthesia—Imiquimod—skin cancer	0.000425	0.00247	CcSEcCtD
Furosemide—Somnolence—Imiquimod—skin cancer	0.000421	0.00244	CcSEcCtD
Furosemide—Hepatobiliary disease—Temozolomide—skin cancer	0.000421	0.00244	CcSEcCtD
Furosemide—Photosensitivity reaction—Fluorouracil—skin cancer	0.000419	0.00244	CcSEcCtD
Furosemide—Erythema multiforme—Dactinomycin—skin cancer	0.000417	0.00242	CcSEcCtD
Furosemide—Erythema—Bleomycin—skin cancer	0.000412	0.00239	CcSEcCtD
Furosemide—Decreased appetite—Imiquimod—skin cancer	0.000411	0.00239	CcSEcCtD
Furosemide—Hypersensitivity—Vemurafenib—skin cancer	0.000409	0.00237	CcSEcCtD
Furosemide—Gastrointestinal disorder—Imiquimod—skin cancer	0.000409	0.00237	CcSEcCtD
Furosemide—Fatigue—Imiquimod—skin cancer	0.000408	0.00237	CcSEcCtD
Furosemide—Pain—Imiquimod—skin cancer	0.000405	0.00235	CcSEcCtD
Furosemide—Dermatitis bullous—Docetaxel—skin cancer	0.000402	0.00233	CcSEcCtD
Furosemide—CA2—head—skin cancer	0.000401	0.00542	CbGeAlD
Furosemide—Asthenia—Vemurafenib—skin cancer	0.000398	0.00231	CcSEcCtD
Furosemide—Urinary tract disorder—Temozolomide—skin cancer	0.000394	0.00229	CcSEcCtD
Furosemide—Pruritus—Vemurafenib—skin cancer	0.000393	0.00228	CcSEcCtD
Furosemide—Lethargy—Docetaxel—skin cancer	0.000392	0.00227	CcSEcCtD
Furosemide—Urethral disorder—Temozolomide—skin cancer	0.000391	0.00227	CcSEcCtD
Furosemide—Feeling abnormal—Imiquimod—skin cancer	0.00039	0.00226	CcSEcCtD
Furosemide—Gastrointestinal pain—Imiquimod—skin cancer	0.000387	0.00225	CcSEcCtD
Furosemide—Hyponatraemia—Docetaxel—skin cancer	0.000385	0.00224	CcSEcCtD
Furosemide—Visual impairment—Temozolomide—skin cancer	0.000385	0.00223	CcSEcCtD
Furosemide—Erythema—Dactinomycin—skin cancer	0.000384	0.00223	CcSEcCtD
Furosemide—Agranulocytosis—Fluorouracil—skin cancer	0.000382	0.00222	CcSEcCtD
Furosemide—Anaemia—Bleomycin—skin cancer	0.000381	0.00221	CcSEcCtD
Furosemide—ALB—lymph node—skin cancer	0.00038	0.00514	CbGeAlD
Furosemide—Diarrhoea—Vemurafenib—skin cancer	0.00038	0.0022	CcSEcCtD
Furosemide—Erythema multiforme—Temozolomide—skin cancer	0.000377	0.00219	CcSEcCtD
Furosemide—Urticaria—Imiquimod—skin cancer	0.000376	0.00218	CcSEcCtD
Furosemide—Body temperature increased—Imiquimod—skin cancer	0.000374	0.00217	CcSEcCtD
Furosemide—Abdominal pain—Imiquimod—skin cancer	0.000374	0.00217	CcSEcCtD
Furosemide—Eye disorder—Temozolomide—skin cancer	0.000373	0.00217	CcSEcCtD
Furosemide—Tinnitus—Temozolomide—skin cancer	0.000372	0.00216	CcSEcCtD
Furosemide—Leukopenia—Bleomycin—skin cancer	0.000369	0.00214	CcSEcCtD
Furosemide—Dizziness—Vemurafenib—skin cancer	0.000367	0.00213	CcSEcCtD
Furosemide—Angiopathy—Temozolomide—skin cancer	0.000362	0.0021	CcSEcCtD
Furosemide—Immune system disorder—Temozolomide—skin cancer	0.000361	0.00209	CcSEcCtD
Furosemide—Dehydration—Docetaxel—skin cancer	0.000357	0.00207	CcSEcCtD
Furosemide—ABCC2—lymph node—skin cancer	0.000356	0.00482	CbGeAlD
Furosemide—Anaemia—Dactinomycin—skin cancer	0.000355	0.00206	CcSEcCtD
Furosemide—Vomiting—Vemurafenib—skin cancer	0.000353	0.00205	CcSEcCtD
Furosemide—Orthostatic hypotension—Docetaxel—skin cancer	0.000351	0.00204	CcSEcCtD
Furosemide—Rash—Vemurafenib—skin cancer	0.00035	0.00203	CcSEcCtD
Furosemide—Dermatitis—Vemurafenib—skin cancer	0.00035	0.00203	CcSEcCtD
Furosemide—Hypersensitivity—Imiquimod—skin cancer	0.000349	0.00202	CcSEcCtD
Furosemide—Headache—Vemurafenib—skin cancer	0.000348	0.00202	CcSEcCtD
Furosemide—Malnutrition—Temozolomide—skin cancer	0.000348	0.00202	CcSEcCtD
Furosemide—Erythema—Temozolomide—skin cancer	0.000348	0.00202	CcSEcCtD
Furosemide—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.000346	0.00201	CcSEcCtD
Furosemide—Cramp muscle—Docetaxel—skin cancer	0.000346	0.00201	CcSEcCtD
Furosemide—Leukopenia—Dactinomycin—skin cancer	0.000344	0.002	CcSEcCtD
Furosemide—Dysgeusia—Temozolomide—skin cancer	0.00034	0.00198	CcSEcCtD
Furosemide—Asthenia—Imiquimod—skin cancer	0.00034	0.00197	CcSEcCtD
Furosemide—Confusional state—Bleomycin—skin cancer	0.000339	0.00197	CcSEcCtD
Furosemide—CA4—lymph node—skin cancer	0.000338	0.00457	CbGeAlD
Furosemide—Anaphylactic shock—Bleomycin—skin cancer	0.000336	0.00195	CcSEcCtD
Furosemide—Pruritus—Imiquimod—skin cancer	0.000335	0.00194	CcSEcCtD
Furosemide—Nausea—Vemurafenib—skin cancer	0.00033	0.00191	CcSEcCtD
Furosemide—Thrombocytopenia—Bleomycin—skin cancer	0.000329	0.00191	CcSEcCtD
Furosemide—Arrhythmia—Fluorouracil—skin cancer	0.000329	0.00191	CcSEcCtD
Furosemide—Vision blurred—Temozolomide—skin cancer	0.000328	0.0019	CcSEcCtD
Furosemide—Diarrhoea—Imiquimod—skin cancer	0.000324	0.00188	CcSEcCtD
Furosemide—Anaemia—Temozolomide—skin cancer	0.000321	0.00186	CcSEcCtD
Furosemide—Anorexia—Bleomycin—skin cancer	0.000321	0.00186	CcSEcCtD
Furosemide—Erythema—Fluorouracil—skin cancer	0.00032	0.00186	CcSEcCtD
Furosemide—Agitation—Temozolomide—skin cancer	0.000319	0.00185	CcSEcCtD
Furosemide—Hypotension—Bleomycin—skin cancer	0.000314	0.00182	CcSEcCtD
Furosemide—Dizziness—Imiquimod—skin cancer	0.000313	0.00182	CcSEcCtD
Furosemide—Vertigo—Temozolomide—skin cancer	0.000312	0.00181	CcSEcCtD
Furosemide—Leukopenia—Temozolomide—skin cancer	0.000311	0.00181	CcSEcCtD
Furosemide—Thrombocytopenia—Dactinomycin—skin cancer	0.000307	0.00178	CcSEcCtD
Furosemide—Paraesthesia—Bleomycin—skin cancer	0.000302	0.00175	CcSEcCtD
Furosemide—Vision blurred—Fluorouracil—skin cancer	0.000302	0.00175	CcSEcCtD
Furosemide—Vomiting—Imiquimod—skin cancer	0.000301	0.00175	CcSEcCtD
Furosemide—Anorexia—Dactinomycin—skin cancer	0.000299	0.00174	CcSEcCtD
Furosemide—Rash—Imiquimod—skin cancer	0.000298	0.00173	CcSEcCtD
Furosemide—Dermatitis—Imiquimod—skin cancer	0.000298	0.00173	CcSEcCtD
Furosemide—Headache—Imiquimod—skin cancer	0.000296	0.00172	CcSEcCtD
Furosemide—Anaemia—Fluorouracil—skin cancer	0.000296	0.00172	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000294	0.00171	CcSEcCtD
Furosemide—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.000293	0.0017	CcSEcCtD
Furosemide—Decreased appetite—Bleomycin—skin cancer	0.000292	0.0017	CcSEcCtD
Furosemide—Renal failure—Docetaxel—skin cancer	0.000291	0.00169	CcSEcCtD
Furosemide—Dry mouth—Temozolomide—skin cancer	0.000289	0.00168	CcSEcCtD
Furosemide—Pain—Bleomycin—skin cancer	0.000288	0.00167	CcSEcCtD
Furosemide—Leukopenia—Fluorouracil—skin cancer	0.000287	0.00166	CcSEcCtD
Furosemide—Confusional state—Temozolomide—skin cancer	0.000286	0.00166	CcSEcCtD
Furosemide—Anaphylactic shock—Temozolomide—skin cancer	0.000284	0.00165	CcSEcCtD
Furosemide—Nausea—Imiquimod—skin cancer	0.000281	0.00163	CcSEcCtD
Furosemide—CA2—lymph node—skin cancer	0.000281	0.00379	CbGeAlD
Furosemide—Hepatobiliary disease—Docetaxel—skin cancer	0.00028	0.00162	CcSEcCtD
Furosemide—Nervous system disorder—Temozolomide—skin cancer	0.000278	0.00161	CcSEcCtD
Furosemide—Thrombocytopenia—Temozolomide—skin cancer	0.000278	0.00161	CcSEcCtD
Furosemide—Feeling abnormal—Bleomycin—skin cancer	0.000277	0.00161	CcSEcCtD
Furosemide—Agranulocytosis—Docetaxel—skin cancer	0.000276	0.0016	CcSEcCtD
Furosemide—SLC22A5—lymph node—skin cancer	0.000276	0.00373	CbGeAlD
Furosemide—Skin disorder—Temozolomide—skin cancer	0.000275	0.0016	CcSEcCtD
Furosemide—Hyperhidrosis—Temozolomide—skin cancer	0.000274	0.00159	CcSEcCtD
Furosemide—Decreased appetite—Dactinomycin—skin cancer	0.000273	0.00158	CcSEcCtD
Furosemide—Fatigue—Dactinomycin—skin cancer	0.00027	0.00157	CcSEcCtD
Furosemide—Anorexia—Temozolomide—skin cancer	0.00027	0.00157	CcSEcCtD
Furosemide—Pain—Dactinomycin—skin cancer	0.000268	0.00156	CcSEcCtD
Furosemide—Urticaria—Bleomycin—skin cancer	0.000267	0.00155	CcSEcCtD
Furosemide—Body temperature increased—Bleomycin—skin cancer	0.000266	0.00154	CcSEcCtD
Furosemide—Confusional state—Fluorouracil—skin cancer	0.000263	0.00153	CcSEcCtD
Furosemide—Urinary tract disorder—Docetaxel—skin cancer	0.000262	0.00152	CcSEcCtD
Furosemide—Anaphylactic shock—Fluorouracil—skin cancer	0.000261	0.00152	CcSEcCtD
Furosemide—Urethral disorder—Docetaxel—skin cancer	0.00026	0.00151	CcSEcCtD
Furosemide—Feeling abnormal—Dactinomycin—skin cancer	0.000258	0.0015	CcSEcCtD
Furosemide—Gastrointestinal pain—Dactinomycin—skin cancer	0.000256	0.00149	CcSEcCtD
Furosemide—Nervous system disorder—Fluorouracil—skin cancer	0.000256	0.00149	CcSEcCtD
Furosemide—Thrombocytopenia—Fluorouracil—skin cancer	0.000256	0.00149	CcSEcCtD
Furosemide—Visual impairment—Docetaxel—skin cancer	0.000256	0.00149	CcSEcCtD
Furosemide—Paraesthesia—Temozolomide—skin cancer	0.000255	0.00148	CcSEcCtD
Furosemide—Somnolence—Temozolomide—skin cancer	0.000252	0.00146	CcSEcCtD
Furosemide—Erythema multiforme—Docetaxel—skin cancer	0.000251	0.00146	CcSEcCtD
Furosemide—Anorexia—Fluorouracil—skin cancer	0.000249	0.00145	CcSEcCtD
Furosemide—Eye disorder—Docetaxel—skin cancer	0.000248	0.00144	CcSEcCtD
Furosemide—Body temperature increased—Dactinomycin—skin cancer	0.000248	0.00144	CcSEcCtD
Furosemide—Abdominal pain—Dactinomycin—skin cancer	0.000248	0.00144	CcSEcCtD
Furosemide—Hypersensitivity—Bleomycin—skin cancer	0.000248	0.00144	CcSEcCtD
Furosemide—Decreased appetite—Temozolomide—skin cancer	0.000247	0.00143	CcSEcCtD
Furosemide—Gastrointestinal disorder—Temozolomide—skin cancer	0.000245	0.00142	CcSEcCtD
Furosemide—Fatigue—Temozolomide—skin cancer	0.000245	0.00142	CcSEcCtD
Furosemide—Hypotension—Fluorouracil—skin cancer	0.000244	0.00142	CcSEcCtD
Furosemide—Pain—Temozolomide—skin cancer	0.000243	0.00141	CcSEcCtD
Furosemide—Constipation—Temozolomide—skin cancer	0.000243	0.00141	CcSEcCtD
Furosemide—Asthenia—Bleomycin—skin cancer	0.000241	0.0014	CcSEcCtD
Furosemide—Angiopathy—Docetaxel—skin cancer	0.000241	0.0014	CcSEcCtD
Furosemide—Immune system disorder—Docetaxel—skin cancer	0.00024	0.00139	CcSEcCtD
Furosemide—Pruritus—Bleomycin—skin cancer	0.000238	0.00138	CcSEcCtD
Furosemide—Arrhythmia—Docetaxel—skin cancer	0.000237	0.00138	CcSEcCtD
Furosemide—Paraesthesia—Fluorouracil—skin cancer	0.000235	0.00136	CcSEcCtD
Furosemide—Feeling abnormal—Temozolomide—skin cancer	0.000234	0.00136	CcSEcCtD
Furosemide—Somnolence—Fluorouracil—skin cancer	0.000232	0.00135	CcSEcCtD
Furosemide—Gastrointestinal pain—Temozolomide—skin cancer	0.000232	0.00135	CcSEcCtD
Furosemide—Malnutrition—Docetaxel—skin cancer	0.000231	0.00134	CcSEcCtD
Furosemide—Erythema—Docetaxel—skin cancer	0.000231	0.00134	CcSEcCtD
Furosemide—Hypersensitivity—Dactinomycin—skin cancer	0.000231	0.00134	CcSEcCtD
Furosemide—Decreased appetite—Fluorouracil—skin cancer	0.000227	0.00132	CcSEcCtD
Furosemide—Dysgeusia—Docetaxel—skin cancer	0.000226	0.00131	CcSEcCtD
Furosemide—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000226	0.00131	CcSEcCtD
Furosemide—Urticaria—Temozolomide—skin cancer	0.000225	0.00131	CcSEcCtD
Furosemide—Asthenia—Dactinomycin—skin cancer	0.000225	0.00131	CcSEcCtD
Furosemide—Body temperature increased—Temozolomide—skin cancer	0.000224	0.0013	CcSEcCtD
Furosemide—Abdominal pain—Temozolomide—skin cancer	0.000224	0.0013	CcSEcCtD
Furosemide—Pain—Fluorouracil—skin cancer	0.000223	0.0013	CcSEcCtD
Furosemide—Muscle spasms—Docetaxel—skin cancer	0.000222	0.00129	CcSEcCtD
Furosemide—Feeling abnormal—Fluorouracil—skin cancer	0.000215	0.00125	CcSEcCtD
Furosemide—Diarrhoea—Dactinomycin—skin cancer	0.000215	0.00125	CcSEcCtD
Furosemide—Vomiting—Bleomycin—skin cancer	0.000214	0.00124	CcSEcCtD
Furosemide—Anaemia—Docetaxel—skin cancer	0.000214	0.00124	CcSEcCtD
Furosemide—Rash—Bleomycin—skin cancer	0.000212	0.00123	CcSEcCtD
Furosemide—Dermatitis—Bleomycin—skin cancer	0.000212	0.00123	CcSEcCtD
Furosemide—Hypersensitivity—Temozolomide—skin cancer	0.000209	0.00121	CcSEcCtD
Furosemide—Urticaria—Fluorouracil—skin cancer	0.000208	0.00121	CcSEcCtD
Furosemide—Leukopenia—Docetaxel—skin cancer	0.000207	0.0012	CcSEcCtD
Furosemide—Body temperature increased—Fluorouracil—skin cancer	0.000207	0.0012	CcSEcCtD
Furosemide—Asthenia—Temozolomide—skin cancer	0.000203	0.00118	CcSEcCtD
Furosemide—Pruritus—Temozolomide—skin cancer	0.000201	0.00117	CcSEcCtD
Furosemide—Nausea—Bleomycin—skin cancer	0.0002	0.00116	CcSEcCtD
Furosemide—Vomiting—Dactinomycin—skin cancer	0.000199	0.00116	CcSEcCtD
Furosemide—Rash—Dactinomycin—skin cancer	0.000198	0.00115	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000195	0.00113	CcSEcCtD
Furosemide—Diarrhoea—Temozolomide—skin cancer	0.000194	0.00113	CcSEcCtD
Furosemide—Hypersensitivity—Fluorouracil—skin cancer	0.000193	0.00112	CcSEcCtD
Furosemide—Dry mouth—Docetaxel—skin cancer	0.000192	0.00112	CcSEcCtD
Furosemide—Confusional state—Docetaxel—skin cancer	0.00019	0.0011	CcSEcCtD
Furosemide—Anaphylactic shock—Docetaxel—skin cancer	0.000189	0.0011	CcSEcCtD
Furosemide—Dizziness—Temozolomide—skin cancer	0.000188	0.00109	CcSEcCtD
Furosemide—Nausea—Dactinomycin—skin cancer	0.000186	0.00108	CcSEcCtD
Furosemide—Shock—Docetaxel—skin cancer	0.000186	0.00108	CcSEcCtD
Furosemide—Nervous system disorder—Docetaxel—skin cancer	0.000185	0.00107	CcSEcCtD
Furosemide—Pruritus—Fluorouracil—skin cancer	0.000185	0.00107	CcSEcCtD
Furosemide—Thrombocytopenia—Docetaxel—skin cancer	0.000185	0.00107	CcSEcCtD
Furosemide—Skin disorder—Docetaxel—skin cancer	0.000183	0.00106	CcSEcCtD
Furosemide—Vomiting—Temozolomide—skin cancer	0.00018	0.00105	CcSEcCtD
Furosemide—Anorexia—Docetaxel—skin cancer	0.00018	0.00104	CcSEcCtD
Furosemide—Rash—Temozolomide—skin cancer	0.000179	0.00104	CcSEcCtD
Furosemide—Diarrhoea—Fluorouracil—skin cancer	0.000179	0.00104	CcSEcCtD
Furosemide—Dermatitis—Temozolomide—skin cancer	0.000179	0.00104	CcSEcCtD
Furosemide—Headache—Temozolomide—skin cancer	0.000178	0.00103	CcSEcCtD
Furosemide—Hypotension—Docetaxel—skin cancer	0.000176	0.00102	CcSEcCtD
Furosemide—Dizziness—Fluorouracil—skin cancer	0.000173	0.001	CcSEcCtD
Furosemide—Paraesthesia—Docetaxel—skin cancer	0.000169	0.000983	CcSEcCtD
Furosemide—Nausea—Temozolomide—skin cancer	0.000168	0.000978	CcSEcCtD
Furosemide—Somnolence—Docetaxel—skin cancer	0.000168	0.000974	CcSEcCtD
Furosemide—Vomiting—Fluorouracil—skin cancer	0.000166	0.000965	CcSEcCtD
Furosemide—Rash—Fluorouracil—skin cancer	0.000165	0.000957	CcSEcCtD
Furosemide—Dermatitis—Fluorouracil—skin cancer	0.000165	0.000956	CcSEcCtD
Furosemide—Decreased appetite—Docetaxel—skin cancer	0.000164	0.000952	CcSEcCtD
Furosemide—Headache—Fluorouracil—skin cancer	0.000164	0.000951	CcSEcCtD
Furosemide—Gastrointestinal disorder—Docetaxel—skin cancer	0.000163	0.000945	CcSEcCtD
Furosemide—Fatigue—Docetaxel—skin cancer	0.000163	0.000944	CcSEcCtD
Furosemide—Pain—Docetaxel—skin cancer	0.000161	0.000936	CcSEcCtD
Furosemide—Constipation—Docetaxel—skin cancer	0.000161	0.000936	CcSEcCtD
Furosemide—Feeling abnormal—Docetaxel—skin cancer	0.000155	0.000902	CcSEcCtD
Furosemide—Nausea—Fluorouracil—skin cancer	0.000155	0.000901	CcSEcCtD
Furosemide—Gastrointestinal pain—Docetaxel—skin cancer	0.000154	0.000895	CcSEcCtD
Furosemide—Body temperature increased—Docetaxel—skin cancer	0.000149	0.000866	CcSEcCtD
Furosemide—Abdominal pain—Docetaxel—skin cancer	0.000149	0.000866	CcSEcCtD
Furosemide—Hypersensitivity—Docetaxel—skin cancer	0.000139	0.000807	CcSEcCtD
Furosemide—Asthenia—Docetaxel—skin cancer	0.000135	0.000786	CcSEcCtD
Furosemide—Pruritus—Docetaxel—skin cancer	0.000133	0.000775	CcSEcCtD
Furosemide—Diarrhoea—Docetaxel—skin cancer	0.000129	0.000749	CcSEcCtD
Furosemide—Dizziness—Docetaxel—skin cancer	0.000125	0.000724	CcSEcCtD
Furosemide—Vomiting—Docetaxel—skin cancer	0.00012	0.000696	CcSEcCtD
Furosemide—Rash—Docetaxel—skin cancer	0.000119	0.00069	CcSEcCtD
Furosemide—Dermatitis—Docetaxel—skin cancer	0.000119	0.00069	CcSEcCtD
Furosemide—Headache—Docetaxel—skin cancer	0.000118	0.000686	CcSEcCtD
Furosemide—Nausea—Docetaxel—skin cancer	0.000112	0.00065	CcSEcCtD
